Citius Pharmaceuticals, Inc. (CTXR)
$0.60-$0.02 (-3.82%) Today
Leonard L. Mazur - OfficerLeonard L. Mazur - OfficerLeonard L. Mazur - OfficerLeonard L. Mazur - OfficerCitius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
No Form 4 activity for CTXR in the last 90 days.
11 Form 4 filings on record, the earliest from Nov 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Myron Z. Holubiak - Officer | Derivative | Warrant to Purchase Common Stock | 31,373 | - | - | |
| Myron Z. Holubiak - Officer | Grant or award | Warrant to Purchase Common Stock | 31,373 | - | - | |
| Myron Z. Holubiak - Officer | Derivative | Warrant to Purchase Common Stock | 22,344 | - | - | |
| Myron Z. Holubiak - Officer | Grant or award | Warrant to Purchase Common Stock | 22,344 | - | - | |
| Leonard L. Mazur - Officer | Derivative | Warrant to Purchase Common Stock | 125,490 | - | - | |
| Leonard L. Mazur - Officer | Grant or award | Warrant to Purchase Common Stock | 125,490 | - | - | |
| Leonard L. Mazur - Officer | Derivative | Warrant to Purchase Common Stock | 89,388 | - | - | |
| Leonard L. Mazur - Officer | Grant or award | Warrant to Purchase Common Stock | 89,388 | - | - | |
| Leonard L. Mazur - Officer | Grant or award | Stock Option (Right to Purchase Common Stock) | 600,000 | $0.00 | - | |
| Myron Z. Holubiak - Officer | Grant or award | Stock Option (Right to Purchase Common Stock) | 350,000 | $0.00 | - | |
| Myron Z. Holubiak - Officer | Grant or award | Stock Option (Right to Buy) | 75,000 | $0.00 | - | |
| Dennis M. McGrath - Director | Grant or award | Stock Option (Right to Purchase Common Stock) | 125,000 | $0.00 | - | |
 Jaime Bartushak - Officer | Grant or award | Stock Option (Right to Purchase Common Stock) | 350,000 | $0.00 | - | |
| Eugene Myron Holuka - Director | Grant or award | Stock Option (Right to Purchase Common Stock) | 125,000 | $0.00 | - | |
 Suren G. Dutia - Director | Grant or award | Stock Option (Right to Purchase Common Stock) | 125,000 | $0.00 | - | |
| Carol Webb - Director | Grant or award | Stock Option (Right to Purchase Common Stock) | 125,000 | $0.00 | - | |
| Myron Czuczman - Officer | Grant or award | Stock Option (Right to Purchase Common Stock) | 300,000 | $0.00 | - | |
| Robert Joseph Smith - Director | Grant or award | Stock Option (Right to Purchase Common Stock) | 125,000 | $0.00 | - |
Citius Pharmaceuticals, Inc. (CTXR) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-08-08. The full record for CTXR runs to 11 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CTXR were filed in the last 90 days.
No insider sales of CTXR were filed in the last 90 days.
This page tracks CTXR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CTXR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
